Postoperative Pain Control in Total Shoulder Arthroplasty

Status Recruiting

Clinical Trial Summary

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.

Clinical Trial Description

In order to reduce narcotic abuse potential, orthopaedic surgeons have explored multimodal pain regimens in addition to regional anesthesia to improve postoperative pain control. One commonly used intervention to reduce postoperative shoulder pain has been the interscalene brachial plexus block. This block provides significant pain relief for shoulder procedures, but has been limited to less than 24 hours even with long acting anesthetics. In the setting of shoulder arthroplasty, this short-term pain control often leads to the need for increased narcotic pain medication. Since shoulder arthroplasty has been steadily increasing in the United States with an annual growth rate of 10.6%, it is imperative to control patients' postoperative pain without increasing their risk for opiate abuse. A potential method for achieving this is by using liposomal bupivacaine in the interscalene blocks. This study is a double blind, prospective, randomized trial to evaluate the postoperative pain profiles among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine. The purpose of this study is to determine if patients undergoing shoulder arthroplasty with an interscalene brachial plexus block with liposomal bupivacaine (study group) or without liposomal bupivacaine (control group) will have differences in postoperative opiate consumption, patient-reported pain, satisfaction with surgery, and shoulder function. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05068960
Study type	Interventional
Source	Scripps Clinic
Contact	Heinz Hoenecke, MD
Phone	858.554.7993
Email	hoenecke.heinz@scrippshealth.org
Status	Recruiting
Phase	Phase 4
Start date	March 1, 2021
Completion date	July 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05900427` - Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients	Phase 4
Completed	`NCT01430468` - Patient Specific Instruments Versus Standard Surgical Instruments	N/A
Completed	`NCT03730597` - Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study	N/A
Completed	`NCT01782872` - Analgesia After Total Shoulder Arthroplasty	Phase 4
Completed	`NCT06109415` - A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.	Phase 4
Active, not recruiting	`NCT03623269` - Posterior Approach to Total Shoulder Arthroplasty
Terminated	`NCT03219983` - Pain Management After Total Shoulder Arthroplasty	Phase 4
Completed	`NCT01726972` - A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Enrolling by invitation	`NCT06133933` - Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
Suspended	`NCT04416932` - Ultrasound After Total Shoulder Arthroplasty
Completed	`NCT04855019` - Post Surgical Pain in Arthroscopic Shoulder	N/A
Recruiting	`NCT06143306` - Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement	Phase 4
Completed	`NCT03887650` - LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs	Phase 4
Active, not recruiting	`NCT02143245` - Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections	N/A
Completed	`NCT01550952` - Interscalene Dynamometer Pilot Study	N/A
Completed	`NCT03969875` - Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
Completed	`NCT04364867` - Exparel for Total Shoulder Arthroplasty	Phase 4